Retirement Planning Co of New England Inc. raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 69.5% during the 4th quarter, Holdings Channel reports. The institutional investor owned 3,803 shares of the company’s stock after buying an additional 1,559 shares during the period. Retirement Planning Co of New England Inc.’s holdings in GE HealthCare Technologies were worth $297,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of the stock. D1 Capital Partners L.P. purchased a new position in shares of GE HealthCare Technologies in the third quarter worth approximately $268,159,000. Van ECK Associates Corp boosted its holdings in shares of GE HealthCare Technologies by 107.3% during the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock worth $378,520,000 after purchasing an additional 2,506,417 shares during the period. State Street Corp lifted its stake in GE HealthCare Technologies by 7.8% in the third quarter. State Street Corp now owns 18,615,890 shares of the company’s stock valued at $1,747,101,000 after acquiring an additional 1,347,114 shares during the last quarter. Massachusetts Financial Services Co. MA acquired a new stake in GE HealthCare Technologies in the third quarter valued at approximately $93,713,000. Finally, Jennison Associates LLC lifted its stake in GE HealthCare Technologies by 124.5% in the fourth quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock valued at $133,659,000 after acquiring an additional 948,017 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.
Analysts Set New Price Targets
Several research firms recently issued reports on GEHC. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their target price for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Citigroup increased their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $98.75.
GE HealthCare Technologies Stock Performance
Shares of GEHC stock opened at $82.47 on Tuesday. The business’s 50 day simple moving average is $87.27 and its 200 day simple moving average is $86.12. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The stock has a market capitalization of $37.71 billion, a PE ratio of 19.05, a PEG ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
- Five stocks we like better than GE HealthCare Technologies
- How to Capture the Benefits of Dividend Increases
- Can TikTok Stock Picks Really Make You Rich?
- How to Invest in Biotech Stocks
- The “Quality” Rotation: Back to Basics Investing
- How to Choose Top Rated Stocks
- Occidental Petroleum: 4 Reasons to Love These Prices
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.